Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Peyronie's Disease, Erectile Dysfunction, and Interstitial Cystitis
Latest Information Update: 02 Nov 2022
At a glance
- Drugs Umbilical cord-derived allogeneic mesenchymal stem cell therapy-Vitro Biopharma (Primary) ; Umbilical cord-derived allogeneic mesenchymal stem cell therapy-Vitro Biopharma (Primary)
- Indications Erectile dysfunction; Interstitial cystitis; Peyronie's disease
- Focus Adverse reactions
- 02 Nov 2022 New trial record